In selective areas of peripheral and coronary vessels, the Bullfrog Micro-Infusion Device is intended for the infusion of diagnostic and therapeutic agents into the vessel wall and perivascular area, or intraluminally.

Device Description

The Mercator MedSystems Bullfrog Micro-Infusion Device is a wire-guided, singleoperator, endovascular catheter that consists of a perpendicular microneedle, which is sheathed by and contained within a semi-rigid polymer actuator balloon. The device is designed to be advanced to target vasculature and hydraulically actuated to move the microneedle through the external elastic lamina to deliver substances to adventitial and perivascular tissues. A compliant stabilizing balloon inflates with the actuator to provide a force opposite the needle tip for proper seating of the needle is retracted within the sheathing structure by vacuuming the hydraulic actuator.

AI/ML Overview

This document is a 510(k) summary for the Mercator MedSystems Bullfrog Micro-Infusion Device.

Based on the provided information, no new performance testing was conducted to support substantial equivalence for the current submission (K161402). The document explicitly states: "No new performance testing was conducted to support substantial equivalence, since the predicate and subject devices are identical in terms of technological characteristics."

Therefore, the requested information about acceptance criteria and reported device performance from a new study proving the device meets those criteria for the K161402 submission cannot be extracted from this document because no such new study was performed.

However, the document mentions that performance testing of the predicate device (K153501) was conducted. This predicate device is also the "Bullfrog Micro-Infusion Device" by Mercator MedSystems, implying the subject device is identical to its predicate in design and performance, except for an update in the Indications for Use.

The document states that the predicate device's performance testing included:

Mechanical and fluid delivery performance
Biocompatibility
Sterilization validation
In-vivo safety and effectiveness studies

It further notes: "All tests met the pre-determined specifications and acceptance criteria."

Since no new study directly addressing acceptance criteria for K161402 is provided, I cannot populate the table or answer the specific questions (2-9) about a study from this application. The information provided pertains to the predicate device's testing, for which details like specific acceptance criteria, sample sizes, expert qualifications, and ground truth methodologies are not included in this 510(k) summary.

Summary

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" written around it. Inside the circle is an abstract symbol that resembles three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

August 18, 2016

Mercator MedSystems, Inc. % Adam Harris Associate Director, Regulatory Affairs Target Health Inc. 261 Madison Ave 24th Floor New York, NY 10016

Re: K161402

Trade/Device Name: Bullfrog Micro-Infusion Device Regulation Number: 21 CFR 870.1210 Regulation Name: Continuous Flush Catheter Regulatory Class: Class II Product Code: KRA Dated: May 17, 2016 Received: Mav 20, 2016

Dear Adam Harris:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in

{1}------------------------------------------------

the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Brian D. Pullin -S

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K161402

Device Name

Mercator MedSystems Bullfrog® Micro-Infusion Device

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
-------------------------------------------------	--

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

5. 510(K) SUMMARY

510(k) Applicant Mercator MedSystems, Inc. 1900 Powell Street, Suite 800 Emeryville, CA 94608 Telephone: (510) 614-4550 Facsimile: (510) 614-4560 Contact Person: Adam Harris, Target Health Phone: (646) 218-2009 Email: aharris@targethealth.com Date of Summary: 9 May 2016 Device Overview Trade Name: Bullfrog® Micro-Infusion Device Common Name: Continuous Flush Infusion Catheter (per 21 CFR 870.1210) Classification: Continuous Flush Infusion Catheter 21 CFR 870.1210 Product Code KRA Panel: Cardiovascular

Predicate Device

510(k)Number	Trade or Proprietary or Model Name	Manufacturer
K153501	Bullfrog® Micro-Infusion Device	Mercator MedSystems

Reference Devices

510(k)Number	Trade or Proprietary or Model Name	Manufacturer
K140637	Peregrine System Infusion Catheter	Ablative Solutions
K062752	MicroSyringe II/Bullfrog Micro-InfusionDevice	Mercator MedSystems

Device Description

{4}------------------------------------------------

perivascular tissues. A compliant stabilizing balloon inflates with the actuator to provide a force opposite the needle tip for proper seating of the needle is retracted within the sheathing structure by vacuuming the hydraulic actuator.

Indications for Use

Technological Characteristics

All materials used in the manufacture of the Bullfrog Micro-Infusion Device are suitable for this use and have been used in several previously cleared products.

Performance Data

No new performance testing was conducted to support substantial equivalence, since the predicate and subject devices are identical in terms of technological characteristics. Performance testing of the predicate device included mechanical and fluid delivery performance, biocompatibility, sterilization validation, in-vivo safety and effectiveness studies. All tests met the pre-determined specifications and acceptance criteria.

Safety and Effectiveness

The Bullfrog Micro-Infusion Device labeling contains instructions for use and any necessary cautions and warnings to assure safe and effective use of the device. The biocompatibility assessment was conducted in accordance with ISO 10993, Biological Evaluation of Medical Devices.

Comparison to Predicate Devices

Aside from the change in the Indications for Use, the Bullfrog Micro-Infusion Device is identical in design and performance to the predicate. The Bullfrog Micro-Infusion Device is also substantially equivalent to the reference devices. Both the predicate device and one of the reference devices, the Peregrine System Infusion Catheter (K140637), relied on the predicate of the other reference device, the MicroSyringe II/Bullfrog Micro-Infusion Device (K062752).

The Bullfrog Micro-Infusion Device is available in three model sizes (2-4 mm. 3-6 mm and 4-8 mm), which is identical to the predicate. Risk analysis has shown that the Bullfrog Micro-Infusion Device has the same risk profile as the predicate.

Regulation Number and Section

§ 870.1210 Continuous flush catheter.

(a)
Identification. A continuous flush catheter is an attachment to a catheter-transducer system that permits continuous intravascular flushing at a slow infusion rate for the purpose of eliminating clotting, back-leakage, and waveform damping.(b)
Classification. Class II (performance standards).